Leflunomida Farmoz

Leflunomide, the active ingredient in Leflunomida Farmoz, is an immunomodulatory agent presented as an oral tablet for oral administration. It is used to manage rheumatoid arthritis and psoriatic arthritis in adult patients, helping to reduce joint inflammation and disease progression.

GNH USA supplies Leflunomida Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under strict GMP conditions for reliable global distribution through a robust logistics network.

Leflunomide is a disease-modifying antirheumatic drug that acts on the immune system to control inflammatory arthritis.

- Rheumatoid arthritis: reduces joint swelling, pain, and slows structural damage. - Psoriatic arthritis: improves skin lesions and joint function, decreasing disease activity. - Adults with moderate to severe disease refractory to other DMARDs: provides an alternative therapeutic option when conventional treatments are insufficient.

Leflunomida Farmoz may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Diarrhea: loose stools that may be mild to moderate. - Nausea: feeling of sickness, sometimes with vomiting. - Elevated liver enzymes: increase in ALT/AST indicating hepatic stress. - Hypertension: rise in blood pressure requiring monitoring. - Alopecia: hair thinning or loss observed in some patients. - Rash: skin eruptions that may be itchy or erythematous.

Serious or Rare Side Effects: - Severe liver injury: jaundice, hepatic failure, may require discontinuation. - Bone marrow suppression: decreased blood cell counts, risk of anemia or infection. - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement.

When prescribing Leflunomida Farmoz, clinicians should observe several precautionary measures to ensure patient safety.

- Liver function monitoring: perform baseline and periodic ALT/AST tests. - Blood pressure assessment: check and control hypertension before and during therapy. - Pregnancy avoidance: drug is contraindicated in pregnancy; effective contraception required. - Hematologic surveillance: monitor complete blood count for signs of bone marrow suppression. - Drug interactions: review concomitant medications for major interaction risks. - Store at below 25°C: keep in original packaging, protect from moisture and direct light.

Leflunomida Farmoz can affect or be affected by other medicines; notable interactions are classified by clinical significance.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect leading to bleeding risk. - Live vaccines: heightened risk of infection due to immunosuppression. - Carbamazepine: induces metabolism, reducing leflunomide plasma levels.

Moderate Interactions (Monitor Closely): - Statins: combined use may increase risk of myopathy. - Methotrexate: additive hepatotoxic potential requiring liver function monitoring.